Hyperfine Inc (HYPR) - Total Liabilities
Based on the latest financial reports, Hyperfine Inc (HYPR) has total liabilities worth $14.26 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore HYPR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Hyperfine Inc - Total Liabilities Trend (2019–2025)
This chart illustrates how Hyperfine Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Hyperfine Inc asset portfolio.
Hyperfine Inc Competitors by Total Liabilities
The table below lists competitors of Hyperfine Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ascot Resources Ltd.
TO:AOT
|
Canada | CA$417.06 Million |
|
South West Pinnacle Exploration Limited
NSE:SOUTHWEST
|
India | Rs1.29 Billion |
|
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
|
USA | $1.69 Million |
|
Kingstate Electronics
TWO:3206
|
Taiwan | NT$1.54 Billion |
|
DarioHealth Corp
NASDAQ:DRIO
|
USA | $41.50 Million |
|
artnet AG Namens-Aktien o.N.
XETRA:ART
|
Germany | €29.69 Million |
|
Pinetree Capital Ltd
TO:PNP
|
Canada | CA$14.19 Million |
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
USA | $118.54 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Hyperfine Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Hyperfine Inc balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hyperfine Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hyperfine Inc (2019–2025)
The table below shows the annual total liabilities of Hyperfine Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $14.26 Million | +44.58% |
| 2024-12-31 | $9.86 Million | +0.62% |
| 2023-12-31 | $9.80 Million | -5.12% |
| 2022-12-31 | $10.33 Million | -36.42% |
| 2021-12-31 | $16.25 Million | +278.34% |
| 2020-12-31 | $4.29 Million | +140.02% |
| 2019-12-31 | $1.79 Million | -- |
About Hyperfine Inc
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture arc… Read more